Full name
MEDIVENA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
32.50.Z - Production of medical devices, instruments, and products, including dental products
64.92.Z - Other forms of credit granting
72.19.Z - Scientific research and development activities
74.10.Z - Specialized design activities
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | -0,6 | -1,2 | -4,4 | -266 |
Gross profit (loss) | -0,6 | -1,2 | 2 | 266,6 |
EBITDA | -0,6 | -1,2 | 1,8 | 253,5 |
Short time liabilities | 1,3 | 1,8 | 3,5 | 96,2 |
Other operating costs | 0 | 0 | 0 | -72,4 |
Equity capital | -0,1 | -1,3 | 11,3 | 981,8 |
Operating profit (EBIT) | -0,6 | -1,2 | 1,8 | 250,5 |
Assets | 1,2 | 1,7 | 19,4 | 1067,8 |
Net profit (loss) | -0,6 | -1,2 | 2 | 266,6 |
Cash | 0,1 | 0,5 | 1,1 | 123,8 |
Net income from sale | 0,6 | 0,2 | 0,2 | -28 |
Liabilities and provisions for liabilities | 1,3 | 2,9 | 8,1 | 176,7 |
Working assets | 1,2 | 1,6 | 18,9 | 1048,5 |
Other income costs | 0 | 0 | 6,2 | -∞ |
Depreciation | 0 | 0 | 0 | 995 |
% | % | % | p.p. | |
Profitability of capital | 705 | 93,3 | 17,6 | -75,7 |
Equity capital to total assets | -6,9 | -76,9 | 58,1 | 135 |
Gross profit margin | -98,5 | -556,5 | 1288 | 1844,5 |
EBITDA Margin | -100 | -554,3 | 1181,9 | 1736,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 789 | 2997 | 8169 | 5172 |
Current financial liquidity indicator | 0.9227693676948547 | 0.9362906813621521 | 5.481504440307617 | 4,6 |
Net dept to EBITDA | 0.09972347319126129 | 0.41364336013793945 | 1.1235932111740112 | 0,7 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane